Ubiquitination functions as a signal to recruit autophagic machinery to damaged organelles and induce their clearance. Here, we report the characterization of FBXO27, a glycoprotein-specific F-box protein that is part of the SCF (SKP1/CUL1/F-box protein) ubiquitin ligase complex, and demonstrate that SCF FBXO27 ubiquitinates glycoproteins in damaged lysosomes to regulate autophagic machinery recruitment. Unlike F-box proteins in other SCF complexes, FBXO27 is subject to N-myristoylation, which localizes it to membranes, allowing it to accumulate rapidly around damaged lysosomes. We also screened for proteins that are ubiquitinated upon lysosomal damage, and identified two SNARE proteins, VAMP3 and VAMP7, and five lysosomal proteins, LAMP1, LAMP2, GNS, PSAP, and TMEM192. Ubiquitination of all glycoproteins identified in this screen increased upon FBXO27 overexpression. We found that the lysosomal protein LAMP2, which is ubiquitinated preferentially on lysosomal damage, enhances autophagic machinery recruitment to damaged lysosomes. Thus, we propose that SCF FBXO27 ubiquitinates glycoproteins exposed upon lysosomal damage to induce lysophagy.
autophagy | FBXO27 | LAMP2 | lysosome | ubiquitin M ost cell-surface proteins and secretory proteins are glycoproteins modified with highly diverse Asn (N)-linked oligosaccharides (N-glycans) that have been implicated in various extracellular processes. N-glycosylation of proteins occurs cotranslationally in the endoplasmic reticulum (ER), and glycoproteins transit from the ER through the Golgi, where N-glycans are trimmed and remodeled before they are delivered to their final destinations. This process results in N-glycans facing either out of cells or on the luminal side of organelles in the secretory pathway, including the ER, Golgi complex, lysosomes, and endosomes. Thus, most molecules that recognize N-glycoproteins are also present in these organelles or on the cell surface. However, a subset of glycosidases or lectins are found either in the cytosol or in nuclei. Peptide-N-glycanase (PNGase) and glycoprotein-specific ubiquitin ligases are cytosolic, and function in the ER-associated degradation pathway in which misfolded glycoproteins are translocated from the ER to the cytosol for degradation by the ubiquitin-proteasome system (1) (2) (3) (4) . In another case, galectin 8, a cytosolic β-galactosidebinding lectin, detects bacterial invasion by binding host glycans exposed on damaged endosomes and lysosomes, and activates xenophagy through the recruitment autophagy receptor NDP52 (5) . Thus, the appearance of N-glycan-modified proteins in the cytosol likely signals the presence of unwanted proteins or organelles.
F-box proteins are receptors for substrates in the SCF (SKP1-CUL1-F-box protein-RBX1) ubiquitin ligase complex. F-box proteins belong to a large protein family comprised of ≈70 proteins in humans. Among these are FBXO2 and FBXO6, which bind to glycoproteins modified with high-mannose N-glycans found in the ER (3, 4) . Biochemical and structural analyses indicate that FBXO2 recognizes the innermost chitobiose structure in N-glycans to direct unfolded glycoproteins to the ER-associated degradation pathway (6, 7) . Furthermore, we found that FBXO27, as well as FBXO2 and FBXO6, bind to glycoproteins modified with high-mannose N-glycans (8). However, FBXO27 has also been reported to bind some glycoproteins modified with complextype N-glycans (9), suggesting that the SCF complex containing FBXO27 has the ability to ubiquitinate glycoproteins that have transited from the ER to other organelles or the plasma membrane. If FBXO27 recognizes complex-type N-glycans, there must be a mechanism through which glycoproteins from these other organelles become exposed to cytoplasmic SCF FBXO27 . Emerging evidence suggests that selective autophagy is used to degrade aggregated proteins, invading pathogens, and damaged or surplus organelles, such as peroxisomes, mitochondria, lysosomes, the nucleus, and the ER (10, 11) . In these systems, ubiquitination often plays a pivotal role in directing the autophagic machinery to substrates (12) . It has been shown that ubiquitin-positive inclusion bodies are degraded by autophagy via p62, an adaptor protein linking ubiquitin to LC3, an autophagosome marker (13) . Furthermore, a key signaling step during mitophagy involves ubiquitination of outer membrane proteins of damaged mitochondria by the ubiquitin ligase Parkin, which is recruited from the cytoplasm by PINK1-mediated phosphorylation of ubiquitin (14) . In another example, autophagy specifically targets invading bacteria to restrict their growth after ubiquitination (15) . Furthermore, damaged lysosomes are selectively sequestered by autophagosomes through a ubiquitindependent mechanism called lysophagy (16, 17) . Although which proteins and how they are ubiquitinated during xenophagy and
Significance
Although lysosomes play a crucial role in autophagy, damaged lysosomes are eliminated by autophagy. The molecular mechanisms that recognize lysosomal damage in cells remain poorly understood, but ubiquitination is a known prerequisite for directing autophagic machinery to damaged lysosomes. FBXO27, a substrate-recognition subunit of the SCF (SKP1/CUL1/F-box protein) ubiquitin ligase complex, localizes to the cytosolic surface of endomembranes and binds glycoproteins. This paper reports that SCF FBXO27 ubiquitinates exposed glycoproteins normally sequestered on the lumenal surface of lysosomes following lysosomal damage, resulting in accelerated recruitment of autophagic machinery.
lysophagy, before autophagy, remain largely unknown, it is plausible that luminal proteins in organelles are exposed to the cytosol following membrane rupture, which may subsequently lead to their ubiquitination.
Here, we demonstrated that FBXO27 is efficiently recruited to lysosomes upon damage, and regulates subsequent accumulation of autophagic machinery. We analyzed proteins ubiquitinated upon lysosomal damage by using the trypsin-resistant tandem ubiquitin-binding entity (TR-TUBE) method, which we recently developed, to identify ubiquitin ligase substrates (18) , and found that SCF FBXO27 ubiquitinates luminal sites on the lysosomal protein LAMP2.
Results

FBXO27
Recognizes N-Glycoproteins and Is Targeted to Membranes via N-Myristoylation. Previous work showed that FBXO2 binds to the innermost chitobiose in high-mannose N-glycans, and that the mutation of Y279 and W280 prevent binding (6) . To determine whether FBXO27 and FBXO6 also recognize the chitobiose, we expressed FLAG-tagged wild-type versions of these proteins, as well as versions containing mutations in residues corresponding to Y279 and W280 in FBXO2, in 293T, or HeLa cells. We analyzed proteins immunoprecipitated using anti-FLAG antibodies on lectin blots probed with ConA, which recognizes high-mannose N-glycans (Fig. 1A) . As we expected, ConA-reactive glycoproteins were not detected in coimmunoprecipitates with either mutant (FBXO6YW/AA or FBXO27FW/AA). Furthermore, we verified that FBXO27 can interact with transferrin receptor (TFRC), an endosomal glycoprotein modified with complex-type N-glycans, as previously reported (9) , suggesting that FBXO27 recognizes various N-glycan structures.
We went on to examine the cellular localization of FBXO27 and observed its localization to membranes, unlike FBXO2 and FBXO6 (Fig. 1B) . Although FBXO2 and FBXO6 were mainly recovered in the cytosolic fraction, FBXO27 was included in the 100,000 × g pellet fraction (Fig. S1A ). We identified a putative N-terminal myristoylation motif (MGXXXS) in FBXO27 (Fig. 1C) . N-myristoylation is the covalent attachment of myristic acid to the N-terminal Gly after the first Met has been removed. To determine whether the Gly confers myristoylation on FBXO27, we used a click chemistry-based approach (Fig. 1D) . We expressed either wild-type FBXO27-FLAG or its G2M mutant, which we predicted to be unmyristoylated. We subsequently incubated the cells with myristic acid-azide, and generated cell lysates that were subjected to the Click-iT reaction for in vitro biotinylation. FBXO27-FLAG proteins and biotinylated proteins were isolated from the biotinylated lysate by using either anti-FLAG antibody or streptavidin (SA) beads, and were analyzed by blotting. Wild-type FBXO27 was biotinylated but not the G2M mutant, indicating that FBXO27 is N-myristoylated in cells.
To determine whether the membranous localization of FBXO27 is a result of its N-myristoylation or to its ability to bind to N-glycans, we proceeded to compare the localization of the G2M mutant and the glycoprotein-binding defective FW/AA mutant ( Fig. 1B and Fig. S1A ). Although the membranous localization was retained in the FW/AA mutant, the G2M mutant protein was detected in whole cells and recovered in cytosolic fraction, indicating that FBXO27 is targeted to membranes via N-myristoylation. We further characterized the subcellular localization of FBXO27 by staining with antibodies for organelle marker proteins (Fig. S1B) . Interestingly, FBXO27 did not colocalize with TOMM20, a protein marker of mitochondria, but colocalized with organelle marker proteins in the membrane trafficking pathway: that is, the ER, Golgi, endosomes, and lysosomes, where glycoproteins reside.
Membrane Targeting and Glycoprotein Binding Activity of FBXO27
Are Important for Its Recruitment of Damaged Lysosomes. Because FBXO27 is found on the cytoplasmic surface of membranes surrounding organelles, it cannot bind to glycoproteins found on the luminal side of these organelles under normal conditions. However, if membrane integrity is impaired, SCF FBXO27 may be able to ubiquitinate glycoproteins in the ruptured organelle. For example, a diverse range of substances, such as silica, bacterial/ viral toxins, and β-amyloid, can all impair lysosomal membranes in vivo. Thus, we next examined the behavior of FBXO27 following disruption of lysosomal membranes using the lysosomotropic compound L-leucyl-L-leucine methyl ester (LLOMe) (19) . To monitor lysosome rupture, we used cells that express GFPgalectin3 (GFP-Gal3) (16) . Gal3 is a galactose-binding lectin found in both the cytoplasm and nucleus in a static state that forms puncta within ruptured lysosomes following LLOMe treatment. We determined the rate of formation of FBXO27 + Gal3 puncta ( ( Fig. S2 A and B) at indicated time points following LLOMe treatment. We also determined the time-course of FBXO27 recruitment by performing dual-color live-cell imaging analysis on cells that express GFP-Gal3 and FBXO27-Halo (Movies S1-S3).
Wild-type FBXO27 started to move to damaged lysosomes soon after LLOMe addition ( Fig. 2 and Movie S1). Although the newly formed Gal3 puncta immediately colocalized with FBXO27 ( Fig. 2 C and D) , some FBXO27
+ lysosomes without Gal3 were also observed (Fig. S2C) . This observation suggests that the recruitment of FBXO27 to damaged lysosomes is as effective as for Gal3. In contrast, the FW/AA mutant did not move to damaged lysosomes even 90 min after LLOMe treatment. The G2M mutant, which can bind to glycoproteins, also migrated to lysosomes following LLOMe treatment but the efficiency of its recruitment from the cytosol to lysosomes was noticeably lower compared with wild-type FBXO27 (Fig. 2 B and  D) . These results indicate that both membrane targeting by N-myristoylation and glycoprotein-binding activity in FBXO27 are strategies for the effective trapping of glycoproteins that appear in the cytosol following membrane rupture.
Latex beads coated with transfection reagents induce endosome damage and are targeted by LC3 + autophagosomes after being endocytosed into the cell (15, 20) . We further determined whether FBXO27 was recruited to damaged endosomes in beadtransfected cells (Fig. S3A) . In cells that express wild-type FBXO27, some prominent FBXO27-rings were observed surrounding endocytosed beads, and these rings colocalized with LC3. Further, ubiquitination of TFRC, a glycoprotein found in endosomes, was accelerated by bead-transfection in cells expressing FBXO27 (Fig. S3B) . These results suggest that FBXO27 is recruited to damaged organelles in which glycoproteins become accessible to FBXO27 and ubiquitinates glycoproteins. Ubiquitination plays important roles in selective autophagy, including mitophagy, xenophagy, and lysophagy (12) . However, it remains unclear which proteins are ubiquitinated during lysophagy. Therefore, we attempted to identify proteins ubiquitinated in response to LLOMe treatment using a dual-enrichment strategy. This strategy uses the TR-TUBE and diGly antibody that recognizes the ubiquitin remnant motif exposed following tryptic digestion of ubiquitinated proteins, in combination with mass spectrometry (18) . TR-TUBE effectively interacts with ubiquitinated substrates in cells, allowing for detection and isolation of ubiquitinated proteins. To this end, 293T cells that express FLAG-TR-TUBE transiently were either treated with LLOMe or left untreated. The dual-enriched ubiquitinated peptides generated from both treated and untreated cells were subjected to MS analysis. In addition, to identify proteins whose ubiquitination was triggered by SCF
FBXO27
, we expressed FLAG-TR-TUBE together with FBXO27 in the presence of LLOMe.
From three independent MS analyses, we identified proteins whose ubiquitination was observed only in the presence of LLOMe (Fig. 3A) . By using the number of peptide spectrum matches (PSMs) as a semiquantitative index, TMEM192, a lysosomal transmembrane protein, and two v/R-SNARE proteins, VAMP3 and VAMP7, were identified as prominent ubiquitinated proteins. However, ubiquitination of these proteins was not stimulated by FBXO27 expression because they are not glycoproteins. TSPAN6, SYNGR1, and MFSD1 are reported to be cell-surface proteins, but they were also ubiquitinated in a reproducible manner upon LLOMe treatment. For lysosomal glycoproteins that were ubiquitinated in response to LLOMe treatment (LAMP1, LAMP2, GNS, TSPAN6, and PSAP), all ubiquitination sites were found on their luminal sides (Table S1) , and the number of PSMs was increased by FBXO27 expression (Fig. 3A) . In particular, the number of PSMs we identified on LAMP1 and LAMP2 were notably increased in FBXO27-expressing cells in the presence of LLOMe, and some ubiquitination sites were observed specifically in the FBXO27-expressing cells. Although FBXO27 expression increased the number of PSMs identified on both LAMP1 and LAMP2, immunoblot analyses using TR-TUBE showed that SCF FBXO27 seemed to ubiquitinate LAMP2 to a greater extent (Fig. 3B) . Although both FBXO2 and FBXO6, as well as FBXO27, could bind to LAMP1 effectively, expressing FBXO2 or FBXO6 did not promote the ubiquitination of LAMP1 in the presence of LLOMe (Fig. S4) .
Next, we compared the time-course of LAMP1 and LAMP2 ubiquitination among 293T cells that express wild-type FBXO27 and its mutants following LLOMe treatment (Fig. 3C) . In cells expressing wild-type FBXO27, ubiquitination started immediately after LLOMe addition and plateaued 1 h later. Moreover, LAMP2 was more effectively ubiquitinated than LAMP1. Compared with cells expressing wild-type FBXO27, the rate of ubiquitination, especially of LAMP2, was low in cells expressing G2M, a result consistent with the different rates of recruitment of wild-type FBXO27 and G2M to damaged lysosomes (Fig. 2) . Furthermore, wild-type FBXO27 binds LAMP2 more effectively than the G2M mutant (Fig. S4A) . To determine whether the difference in LAMP1 and LAMP2 ubiquitination efficiency is a result of differences in their cellular abundance, we analyzed ubiquitination rates in HeLa cells, which contain three times more LAMP1 than LAMP2 (21) . Similar to results from 293T cells, LAMP2 was more effectively ubiquitinated compared LAMP1 in HeLa cells expressing wild-type FBXO27, whereas the rate of LAMP1 ubiquitination was almost the same in cells expressing either FBXO27 or the G2M mutant (Fig. 3D) . These results suggest that SCF FBXO27 ubiquitinates LAMP2 more effectively than LAMP1, regardless of its relative abundance in cells.
We next examined the ubiquitin chain type found on LAMP2 modified by SCF FBXO27 . Because exogenously expressed LAMP2 was not ubiquitinated by SCF FBXO27 (Fig. S5A) , we used Erythrina Cristagalli (ECA) lectin to enrich for endogenous LAMP2 (Fig.  S5B) . By using TR-TUBE and ECA lectin, we enriched for LAMP2 ubiquitinated by SCF FBXO27 to quantify its ubiquitin linkage based on the parallel reaction monitoring (PRM) method using standard absolute quantification (AQUA) peptide as internal spikes (22) (Fig. S5C) . Compared with LAMP2 from cells expressing the FW/AA mutant, K48 chains on LAMP2 were increased in cells expressing FBXO27. We further assessed the ubiquitination pattern on LAMP2 by using linkage-specific antiubiquitin antibodies (Fig. S5D) . These results indicated that SCF FBXO27 generates K48-linked ubiquitin chains on LAMP2 in damaged lysosomes.
FBXO27 Expression Enhances Recruitment of Autophagic Machinery
to Damaged Lysosomes. FBXO27 expression is restricted to several tissues, including the brain. Expression was not detected in 293T cells and HeLa cells by immunoblotting. We therefore searched for cell lines that express FBXO27 endogenously using the Body Atlas database in the NEXTBIO search engine. We identified the pancreatic adenocarcinoma cell line PANC-1 as a candidate, and verified FBXO27 expression in PANC-1 cells (Fig. 3E) . Endogenous FBXO27 was also recovered in the membrane fraction, suggesting that it binds to endomembranes via N-myristoylation (Fig. 3F) .
We next examined the ubiquitination of LAMP1 and LAMP2 during LLOMe treatment in PANC-1 cells. To assess ubiquitination by endogenous FBXO27, we first established FBXO27 knockout PANC-1 cells using the CRSPR/Cas9 method. Although we were unable to detect LAMP1 ubiquitination, LAMP2 was ubiquitinated after LLOMe treatment in a time-dependent manner in wild-type cells (Fig. 3G) . In contrast, LLOMe treatment did not induce LAMP2 ubiquitination in FBXO27 KO cells, indicating that LAMP2 in damaged lysosomes is ubiquitinated by endogenous SCF FBXO27 . To determine whether FBXO27 expression affects the recruitment of autophagic machinery to damaged lysosomes, we measured the accumulation of LC3 + lysosomes at indicated time points following LLOMe treatment (Fig. S6 A-C) . We used LAMP1 as a lysosomal marker, and observed that LC3 colocalized with ∼50% of LAMP1 puncta in wild-type PANC-1 cells 30 min after LLOMe addition. Colocalization was significantly reduced in LLOMe-treated FBXO27 KO PANC-1 cells (Fig.  S6B) , and this reduction was suppressed by FBXO27 expression (Fig. S6C) . We also measured the colocalization of LC3 and GFP-Gal3, and found that LC3 colocalized with more than half 293T cells were transfected with plasmids encoding FLAG-TR-TUBE with or without FBXO27, and cells were treated with or without LLOMe for 3 h before harvesting. The ubiquitinated proteins were identified by the dual-enrichment method using anti-FLAG and anti-diGly antibodies, followed by MS analysis. Total PSM numbers for identified proteins in LLOMe-treated cells expressing either FLAG tag alone (blue bars) or FBXO27 (red bars) with FLAG-TR-TUBE are shown. Glycoproteins are shown in red (G). All of the ubiquitination sites in the indicated proteins are shown in Table S1 . (B) Ubiquitination assay for LAMP1 and LAMP2. Cells were transfected with plasmids encoding FLAG-TR-TUBE and either empty vector control, FBXO27 (O27), or its dominant-negative mutant (ΔF). the Gal3 puncta 30 min after adding LLOMe to transfected wildtype PANC-1 cells expressing GFP-Gal3 (Fig. 4 A and B) . In contrast, the proportion of LC3
+ puncta was significantly lower in FBXO27 KO cells, suggesting that SCF FBXO27 is required for proper targeting of LC3 to disrupted lysosomes. Supporting this idea, the reduced colocalization of LC3 and GFP-Gal3 in FBXO27 KO cells was rescued by transgenic FBXO27 expression. Endogenous p62, an autophagy receptor, also colocalized with LAMP2 in wild-type PANC-1 cells that had been treated with LLOMe for 30 min, and this colocalization was significantly reduced in FBXO27 KO cells (Fig. 4 C and D) .
To determine if FBXO27-dependent LC3 recruitment to lysosomes can be triggered by agents other than LLOMe, we treated cells with silica, another lysosome-damaging agent (16) . In this case, most Gal3 puncta colocalized with LC3 and ubiquitin in PANC-1 cells within an hour of silica addition (Fig. S7) . Similar to LLOMe results, the rate of LC3 + Gal3 puncta formation was significantly reduced in both FBXO27 KO cells and when FBXO27 was depleted by siRNA treatment. Thus, the recruitment of autophagic machinery to lysosomes by SCF FBXO27 is likely because of lysosomal damage, rather than an artifact of LLOMe treatment.
In the absence of lysosomal damage, LAMP1 and LAMP2 proteins are relatively stable in both wild-type and FBXO27 KO PANC-1 cells (Fig. S6 D and E) . However, after addition of LLOMe, we observe a gradual degradation of these proteins in wild-type, but not FBXO27 KO, PANC-1 cells (Fig. S6 F and G) . These results are consistent with a model where exposed glycoproteins, including LAMP1 and LAMP2, recruit SCF FBXO27 . SCF FBXO27 ubiquitinates these glycoproteins, causing subsequent recruitment of autophagic machinery, leading to degradation of these proteins during lysophagy. To examine whether FBXO27 regulates clearance of damaged lysosomes, we next monitored clearance of GFP-Gal3 puncta at various time points after LLOMe washout, in wild-type PANC-1 cells and in PANC-1 cells with FBXO27, CUL1, LAMP1, or LAMP2 knocked down. In control cells, the proportion of cells with more than five Gal3 puncta gradually dropped over time after LLOMe washout. Although 100% of cells had more than five Gal3 puncta immediately after LLOMe treatment, this number fell to 25% 12 h after washout. In contrast, in cells depleted of FBXO27, CUL1, LAMP1, or LAMP2 by siRNA, a significant delay in clearance of Gal3 puncta was observed (Fig. 4E and Fig. S8 ). These results suggest that ubiquitination of lysosomal glycoproteins by SCF FBXO27 accelerates recruitment of autophagic machinery to damaged lysosomes, leading to accelerated clearance.
Discussion
A diverse range of substances can rupture endosomal and lysosomal membranes in vivo, and the resulting damaged organelles are eliminated by a type of autophagy called organellophagy. Similar to PINK1/Parkin-mediated mitophagy, ubiquitination of damaged endosomes or lysosomes is involved in damage recognition and in recruiting autophagic machinery. However, the mechanisms underlying such ubiquitination are unclear. In this study, we showed that membrane-bound FBXO27 is rapidly recruited to ruptured lysosomes following LLOMe treatment. Lysosomal membrane rupture renders LAMP2 accessible to recognition by FBXO27 and ubiquitination by SCF Over 30 cells were counted (n = 3). Statistical significance was evaluated using one-way ANOVA with posttesting according to Tukey's test. ***P < 0.001, **P < 0.01. (E) Quantification of the percentage of cells with more than five GFP-Gal3 puncta per cell for each condition. PANC-1 cells stably expressing GFP-Gal3 were treated with siRNA against luciferase (Cont), FBXO27, CUL1, LAMP1, or LAMP2. Cells were subsequently treated with LLOMe for 1 h. After LLOMe washout, cells were fixed at the indicated times and stained with DAPI. The number of Gal3 puncta per cell was counted in over 250 cells (n = 3). The data represent means ± SD. Statistical significance was evaluated using two-way ANOVA with posttesting according to Bonferroni's test. ****P < 0.0001, ***P < 0.001, *P < 0.03. (F) Schematic diagram of LAMP2 ubiquitination by SCF FBXO27 in damaged lysosomes for recruitment of autophagic machinery.
damaged lysosomes enhances the recruitment of autophagic machinery, such as p62 and LC3 (Fig. 4F) . Although no ubiquitination sites on LAMP2 have been referenced in the proteomic database, SCF FBXO27 clearly ubiquitinated LAMP2 upon LLOMe treatment (Fig. 3) . LAMP1 and LAMP2, major lysosomal membrane proteins that show 37% identity in humans, are highly glycosylated. It is unclear why LAMP2 is more effectively ubiquitinated by SCF FBXO27 ; however, because the efficiency of LAMP1 and LAMP2 ubiquitination is similar in cells that express the G2M mutant, the membrane targeting of FBXO27 appears to be important for LAMP2 targeting. All three glycoprotein-specific F-box proteins-FBXO2, FBXO6, and FBXO27-recognize the innermost chitobiose structure found in all N-glycans and can bind to LAMP1, but only FBXO27 is N-myristoylated and ubiquitinates LAMP1 and LAMP2 (Fig. S4) . This modification may affect substraterecognition, as well as substrate recruitment efficiency.
Knockdown of FBXO27, CUL1, LAMP1, or LAMP2 slows down, but does not abolish lysophagy (Fig. 4E) , indicating that other mechanisms inducing lysophagy exist in PANC-1 cells. Consistent with this finding, Chauhan et al. reported that TRIM16, a RING-type ubiquitin ligase, recognizes endomembrane damage in cooperation with Gal-3 and ULK1, and adds K63-linked ubiquitin to the lysosomal membrane (23) . Because TRIM16 is expressed globally in cells, it is likely that both TRIM16-dependent and FBXO27-dependent lysophagy pathways are operating in PANC-1 cells.
Although previous reports, including Chauhan et al., demonstrate that K63-linked ubiquitin chains are important for selective autophagy including lysophagy (23, 24) , our data indicate that K48-linked ubiquitination is also important. Although the role in lysophagy at first seems inconsistent with reports implicating K48-linkages in proteasomal degradation, a recent study suggests that pathway choice between proteasomal degradation and selective autophagy is largely regulated by the oligomerization state of ubiquitin receptors, rather than specific linkage type (25) .
FBXO27 is expressed at high levels in specific tissues, including the nervous system, suggesting that tissues with high energy requirements may require the FBXO27-dependent pathway in addition to K63 pathways to accelerate clearance upon lysosomal damage. Many lines of evidence indicate that abnormal protein accumulation causes neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. Under these pathological situations, several factors can disrupt lysosomal membrane integrity directly and induce rapid lysosomedependent cell death (26, 27) . In addition to lysosomal rupture, these pathologies may induce yet unknown damage to other organelles, and it is possible that FBXO27 migrates to the damaged organelles and causes the subsequent ubiquitination of glycoproteins. Because the appearance of glycoproteins in the cytosol is aberrant, monitoring by cytosolic ubiquitin ligases is a likely cellular defense system against disease. Further studies to identify physiological substrates for FBXO27 in neuronal cells may help to advance our understanding of still unknown pathways leading to glycoprotein appearance in the cytosol.
Materials and Methods
Myristoylation Assay. Cells were treated with 40 μM myristic acid azide (Thermo Fisher Scientific) for 12 h before lysis. Cell lysates were subjected to the Click-iT reaction for biotinylation by using the Click-iT protein reaction kit (Thermo Fisher Scientific).
Immunofluorescence and Microscopy. Cells were cultured in glass-bottomed 35-mm dishes, fixed with 4% paraformaldehyde dissolved in PBS for 10 min, and permeabilized with 50 μg/mL digitonin in PBS for 10 min. Fixed cells were first stained with the primary antibodies described in SI Materials and Methods, and subsequently stained with the following secondary antibodies: mouse, rat, or rabbit conjugated to either Alexa Fluor-488, -568, or -633 (Life Technologies). Samples were mounted and observed with a laserscanning confocal microscope (LSM710; Carl Zeiss) with a Plan-Apochromat 63× NA 1.4 oil differential interference contrast objective lens.
Additional information is provided in SI Materials and Methods.
